These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 20032471)

  • 1. Nonsynonymous mutations within APOB in human familial hypobetalipoproteinemia: evidence for feedback inhibition of lipogenesis and postendoplasmic reticulum degradation of apolipoprotein B.
    Zhong S; Magnolo AL; Sundaram M; Zhou H; Yao EF; Di Leo E; Loria P; Wang S; Bamji-Mirza M; Wang L; McKnight CJ; Figeys D; Wang Y; Tarugi P; Yao Z
    J Biol Chem; 2010 Feb; 285(9):6453-64. PubMed ID: 20032471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein Metabolism in APOB L343V Familial Hypobetalipoproteinemia.
    Hooper AJ; Heeks L; Robertson K; Champain D; Hua J; Song S; Parhofer KG; Barrett PH; van Bockxmeer FM; Burnett JR
    J Clin Endocrinol Metab; 2015 Nov; 100(11):E1484-90. PubMed ID: 26323024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homozygous familial hypobetalipoproteinemia: A Turkish case carrying a missense mutation in apolipoprotein B.
    Yilmaz BS; Mungan NO; Di Leo E; Magnolo L; Artuso L; Bernardis I; Tumgor G; Kor D; Tarugi P
    Clin Chim Acta; 2016 Jan; 452():185-90. PubMed ID: 26612772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel nontruncating APOB gene mutation, R463W, causes familial hypobetalipoproteinemia.
    Burnett JR; Shan J; Miskie BA; Whitfield AJ; Yuan J; Tran K; McKnight CJ; Hegele RA; Yao Z
    J Biol Chem; 2003 Apr; 278(15):13442-52. PubMed ID: 12551903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatase and tensin homolog (PTEN) regulates hepatic lipogenesis, microsomal triglyceride transfer protein, and the secretion of apolipoprotein B-containing lipoproteins.
    Qiu W; Federico L; Naples M; Avramoglu RK; Meshkani R; Zhang J; Tsai J; Hussain M; Dai K; Iqbal J; Kontos CD; Horie Y; Suzuki A; Adeli K
    Hepatology; 2008 Dec; 48(6):1799-809. PubMed ID: 19026012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Missense mutations in APOB within the betaalpha1 domain of human APOB-100 result in impaired secretion of ApoB and ApoB-containing lipoproteins in familial hypobetalipoproteinemia.
    Burnett JR; Zhong S; Jiang ZG; Hooper AJ; Fisher EA; McLeod RS; Zhao Y; Barrett PH; Hegele RA; van Bockxmeer FM; Zhang H; Vance DE; McKnight CJ; Yao Z
    J Biol Chem; 2007 Aug; 282(33):24270-83. PubMed ID: 17588943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial hypobetalipoproteinemia due to apolipoprotein B R463W mutation causes intestinal fat accumulation and low postprandial lipemia.
    Noto D; Cefalù AB; Cannizzaro A; Minà M; Fayer F; Valenti V; Barbagallo CM; Tuttolomondo A; Pinto A; Sciumè C; Licata G; Averna M
    Atherosclerosis; 2009 Sep; 206(1):193-8. PubMed ID: 19344897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular diagnosis of hypobetalipoproteinemia: an ENID review.
    Tarugi P; Averna M; Di Leo E; Cefalù AB; Noto D; Magnolo L; Cattin L; Bertolini S; Calandra S
    Atherosclerosis; 2007 Dec; 195(2):e19-27. PubMed ID: 17570373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations.
    Di Leo E; Magnolo L; Bertolotti M; Bourbon M; Carmo Pereira S; Pirisi M; Calandra S; Tarugi P
    Clin Genet; 2008 Sep; 74(3):267-73. PubMed ID: 18492086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apolipoprotein B gene mutations and fatty liver in Japanese hypobetalipoproteinemia.
    Katsuda S; Kawashiri MA; Inazu A; Tada H; Tsuchida M; Kaneko Y; Nozue T; Nohara A; Okada T; Kobayashi J; Michishita I; Mabuchi H; Yamagishi M
    Clin Chim Acta; 2009 Jan; 399(1-2):64-8. PubMed ID: 18848826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant hepatic expression of PPARgamma2 stimulates hepatic lipogenesis in a mouse model of obesity, insulin resistance, dyslipidemia, and hepatic steatosis.
    Zhang YL; Hernandez-Ono A; Siri P; Weisberg S; Conlon D; Graham MJ; Crooke RM; Huang LS; Ginsberg HN
    J Biol Chem; 2006 Dec; 281(49):37603-15. PubMed ID: 16971390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional analysis of two novel splice site mutations of APOB gene in familial hypobetalipoproteinemia.
    Di Leo E; Magnolo L; Pinotti E; Martini S; Cortella I; Vitturi N; Rabacchi C; Wunsch A; Pucci F; Bertolini S; Calandra S; Tarugi P
    Mol Genet Metab; 2009 Feb; 96(2):66-72. PubMed ID: 19084451
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Vanhoye X; Janin A; Caillaud A; Rimbert A; Venet F; Gossez M; Dijk W; Marmontel O; Nony S; Chatelain C; Durand C; Lindenbaum P; Rieusset J; Cariou B; Moulin P; Di Filippo M
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced intestinal fat absorptive capacity but enhanced susceptibility to diet-induced fatty liver in mice heterozygous for ApoB38.9 truncation.
    Lin X; Yue P; Xie Y; Davidson NO; Sakata N; Ostlund RE; Chen Z; Schonfeld G
    Am J Physiol Gastrointest Liver Physiol; 2005 Jul; 289(1):G146-52. PubMed ID: 15790761
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of APOB, SAR1B, ANGPTL3, and MTTP in patients with primary hypocholesterolemia in a clinical laboratory setting: Evidence supporting polygenicity in mutation-negative patients.
    Blanco-Vaca F; Martin-Campos JM; Beteta-Vicente Á; Canyelles M; Martínez S; Roig R; Farré N; Julve J; Tondo M
    Atherosclerosis; 2019 Apr; 283():52-60. PubMed ID: 30782561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The production of 85 kDa N-terminal fragment of apolipoprotein B in mutant HepG2 cells generated by targeted modification of apoB gene occurs by ALLN-inhibitable protease cleavage during translocation.
    Srivastava N; Cefalu AB; Noto D; Schonfeld G; Averna M; Srivastava RA
    Biochem Biophys Res Commun; 2010 Aug; 398(4):665-70. PubMed ID: 20609357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia.
    Di Leo E; Magnolo L; Lancellotti S; Crocè L; Visintin L; Tiribelli C; Bertolini S; Calandra S; Tarugi P
    J Med Genet; 2007 Mar; 44(3):219-24. PubMed ID: 17158591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-alcoholic steatohepatitis-related cirrhosis in a patient with APOB L343V familial hypobetalipoproteinaemia.
    Heeks LV; Hooper AJ; Adams LA; Robbins P; Barrett PH; van Bockxmeer FM; Burnett JR
    Clin Chim Acta; 2013 Jun; 421():121-5. PubMed ID: 23694813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Rare Mutation in The
    Musialik J; Boguszewska-Chachulska A; Pojda-Wilczek D; Gorzkowska A; Szymańczak R; Kania M; Kujawa-Szewieczek A; Wojcieszyn M; Hartleb M; Więcek A
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32093271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PCSK9 dominant negative mutant results in increased LDL catabolic rate and familial hypobetalipoproteinemia.
    Cariou B; Ouguerram K; Zaïr Y; Guerois R; Langhi C; Kourimate S; Benoit I; Le May C; Gayet C; Belabbas K; Dufernez F; Chétiveaux M; Tarugi P; Krempf M; Benlian P; Costet P
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2191-7. PubMed ID: 19762784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.